5F-ADBICA

5F-ADBICA is a designer drug that belongs to the cannabinoid class. It is an analogue of ADBICA, a cannabinoid receptor agonist. 5F-ADBICA was first identified in Japan in 2013. It is illegal in some countries due to its psychoactive properties.

Chemistry[edit | edit source]

5F-ADBICA is a synthetic cannabinoid that is structurally related to ADBICA. It has a molecular formula of C20H28FN3O3 and a molecular weight of 377.46 g/mol. The compound is characterized by a fluoropentyl chain attached to the indole core of ADBICA.

Pharmacology[edit | edit source]

As a synthetic cannabinoid, 5F-ADBICA acts as an agonist at the cannabinoid receptors, mimicking the effects of cannabis. However, the exact mechanism of action and the full spectrum of its effects are not fully understood.

Legal Status[edit | edit source]

5F-ADBICA is classified as a Schedule I controlled substance in the United States. It is also illegal in several other countries, including Japan and Sweden.

Health Risks[edit | edit source]

The use of 5F-ADBICA can lead to a range of adverse health effects, including psychosis, seizures, and cardiac arrest. Due to its potency and the lack of research on its effects, it is considered a high-risk substance.

See Also[edit | edit source]

5F-ADBICA Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.